Leading technology website, TechCrunch, featured OurCrowd’s portfolio company Syqe Medical. The company has developed a pocket-sized metered-dose cannabis inhaler, poised to become the most advanced and versatile inhalation-based drug delivery platform of its kind.
While the government is deliberating new reforms to expand Israel’s cannabis industry, it’s likely that the so-called reforms will cause more problems than they will solve, as is often the case with government meddling. The proposal will also have to pass several committees before it’s voted on in the Knesset (Israel’s parliament).
Luckily, Israeli startups know better than to wait for the government to act. In January, Cigarette conglomerate Philip Morris International announced that it will invest $20 million in Syqe Medical, an Israeli start-up that developed the world’s first precision metered dose inhaler for medical use, according to Israeli news site Calcalist.
Syqe raised $2,232,593 from OurCrowd investors in June 2015.
Read more on TechCrunch here.